AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 30137647 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 800 IU/day
Number of subjects: 194
Study 30137647 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 1600 IU/day
Number of subjects: 194
Study 30137647 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 2400 IU/day
Number of subjects: 194
Study 30137647 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 3200 IU/day
Number of subjects: 194
Study 30137647 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 4000 IU/day
Number of subjects: 194
Study 30137647 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 4800 IU/day
Number of subjects: 194
Study 30137647 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 194
Study 27903247 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional chemoradiotherapy (CRT)
Number of subjects: 150
Study 27903247 — intervention group
Group type: COMPARATOR
Intervention: Short-term radiotherapy (RT)
Number of subjects: 150
Study 25271117 — intervention group
Group type: EXPERIMENTAL
Intervention: retrospective continuous glucose monitoring (r-CGM)
Number of subjects: 92
Study 25271117 — intervention group
Group type: COMPARATOR
Intervention: self-monitoring of blood glucose (SMBG)
Number of subjects: 92
Study 25271117 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin initiation and titration
Number of subjects: 92
Study 22541308 — intervention group
Group type: EXPERIMENTAL
Intervention: Intense rehabilitation therapies with acupuncture (5 times per week for 12 weeks)
Number of subjects: 75
Study 22541308 — intervention group
Group type: COMPARATOR
Intervention: Intense rehabilitation therapies without acupuncture (5 times per week for 12 weeks)
Number of subjects: 75
Study 22541308 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture added to rehabilitation therapies (weeks 16-28)
Number of subjects: 75
Study 22541308 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined groups after intense therapies
Number of subjects: 75
Study 22541308 — intervention group
Group type: EXPERIMENTAL
Intervention: Children with GMFCS II level
Number of subjects: 75
Study 20547926 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher collateral grade
Number of subjects: 2173
Study 20547926 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention
Number of subjects: 2173
Study 20547926 — intervention group
Group type: COMPARATOR
Intervention: Medical therapy alone
Number of subjects: 2173
Study 19011792 — intervention group
Group type: EXPERIMENTAL
Intervention: 50% N2O + 50% O2
Number of subjects: 80
Study 19011792 — intervention group
Group type: COMPARATOR
Intervention: Room air
Number of subjects: 80
Study 19011792 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 80
Study 15632815 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexible diuretic titration (DT)
Number of subjects: 66
Study 15632815 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 66
Study 11854636 — intervention group
Group type: EXPERIMENTAL
Intervention: Gestational diabetes mellitus
Number of subjects: 110
Study 11854636 — intervention group
Group type: EXPERIMENTAL
Intervention: Single abnormal glucose tolerance test value
Number of subjects: 110
Study 11854636 — intervention group
Group type: COMPARATOR
Intervention: Normal oral glucose tolerance test results
Number of subjects: 110
Study 10188899 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-operative chemotherapy (mitomycin-C 8 mg m(‐2), vinblastine 6 mg m(‐2), cisplatin 50 mg m(‐2) - MVP) followed by surgery
Number of subjects: 22
Study 10188899 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 22
Study 7564895 — intervention group
Group type: EXPERIMENTAL
Intervention: Hexyl nicotinate (HN) 0.5% ethanol solution
Number of subjects: 16
Study 7564895 — intervention group
Group type: EXPERIMENTAL
Intervention: Methyl nicotinate (MN) 5% ethanol solution
Number of subjects: 16
Study 7564895 — intervention group
Group type: EXPERIMENTAL
Intervention: Both HN and MN
Number of subjects: 16
Study 2250114 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined heat and radiation therapy (thermoradiotherapy)
Number of subjects: 56
Study 2250114 — intervention group
Group type: COMPARATOR
Intervention: Control group (only irradiated)
Number of subjects: 56
Study 2250114 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermoradiotherapy
Number of subjects: 56
Study 6985998 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g of aspirin per day
Number of subjects: 4524
Study 6985998 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4524
Study 30859961 — intervention group
Group type: EXPERIMENTAL
Intervention: Amphetamine extended-release oral suspension (AMPH EROS)
Number of subjects: 18
Study 30859961 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 28981764 — intervention group
Group type: EXPERIMENTAL
Intervention: Community Health Worker (CHW) antenatal and postnatal home visits (average of 4.1 visits per mother)
Number of subjects: 15
Study 28981764 — intervention group
Group type: EXPERIMENTAL
Intervention: Community Health Worker (CHW) antenatal and postnatal home visits
Number of subjects: 15
Study 26470906 — intervention group
Group type: EXPERIMENTAL
Intervention: Trauma-Focused Cognitive-Behavioral Therapy (TF-CBT)
Number of subjects: 107
Study 22814294 — intervention group
Group type: EXPERIMENTAL
Intervention: NOTCH1±FBXW7(Double)
Number of subjects: 162
Study 22814294 — intervention group
Group type: COMPARATOR
Intervention: NOTCH1(WT)FBXW7(WT)
Number of subjects: 162
Study 22814294 — intervention group
Group type: EXPERIMENTAL
Intervention: NOTCH1(Single)FBXW7(WT)
Number of subjects: 162
Study 22201703 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based program for problem drinkers
Number of subjects: 156
Study 19236279 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV-6/11/16/18 vaccine
Number of subjects: 17622
Study 16062012 — intervention group
Group type: EXPERIMENTAL
Intervention: High-impact and/or weight-bearing exercise
Number of subjects: 0
Study 16062012 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 0
Study 16062012 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking cessation
Number of subjects: 0
Study 16062012 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 12362098 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with appendicitis
Number of subjects: 30
Study 12362098 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 30
Study 10435372 — intervention group
Group type: EXPERIMENTAL
Intervention: 99mTc tetrofosmin gated SPECT
Number of subjects: 17
Study 10435372 — intervention group
Group type: COMPARATOR
Intervention: 18F FDG PET
Number of subjects: 17
Study 8771219 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined cognitive-behavioral/psychopharmacological treatment (nortriptyline or fluoxetine in AN-R, fluoxetine or amineptine in AN-BP)
Number of subjects: 80
Study 8771219 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine treatment in AN-R patients
Number of subjects: 80
Study 8771219 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine or amineptine treatment in AN-BP patients
Number of subjects: 80
Study 8771219 — intervention group
Group type: COMPARATOR
Intervention: Healthy volunteers (control group)
Number of subjects: 80
Study 2251437 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol (100 mcg, 2 puffs)
Number of subjects: 20
Study 2251437 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxitropium bromide (100 mcg, 2 puffs)
Number of subjects: 20
Study 2251437 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of Salbutamol and Oxitropium bromide
Number of subjects: 20
Study 6109480 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A - BCAA solution with 12 g N (852 mmol) and 41.1% BCAA
Number of subjects: 20
Study 6109480 — intervention group
Group type: COMPARATOR
Intervention: Group B - Control solution with 18 g N (1278 mmol) and 21.1% BCAA
Number of subjects: 20
Study 31965140 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher egg intake (≥7 egg/wk)
Number of subjects: 177000
Study 31354159 — intervention group
Group type: EXPERIMENTAL
Intervention: Crosier-shaped catheter technique
Number of subjects: 218
Study 31354159 — intervention group
Group type: COMPARATOR
Intervention: Straight catheter technique
Number of subjects: 218
Study 28114265 — intervention group
Group type: EXPERIMENTAL
Intervention: NSAIDs (ketorolac tromethamine 10 mg, 2 tablets daily for 2 days and amoxicillin 500 mg, 3 tablets daily for 7 days) + corticosteroids (betamethasone 2 mL injection within 10 hours after surgery)
Number of subjects: 30
Study 28114265 — intervention group
Group type: COMPARATOR
Intervention: NSAIDs (ketorolac tromethamine 10 mg, 2 tablets daily for 2 days and amoxicillin 500 mg, 3 tablets daily for 7 days)
Number of subjects: 30
Study 25894843 — intervention group
Group type: EXPERIMENTAL
Intervention: Homotaurine 100 mg
Number of subjects: 47
Study 25894843 — intervention group
Group type: COMPARATOR
Intervention: Control group (no homotaurine)
Number of subjects: 47
Study 24359285 — intervention group
Group type: EXPERIMENTAL
Intervention: Program SI! intervention
Number of subjects: 2062
Study 21831931 — intervention group
Group type: EXPERIMENTAL
Intervention: Reinforced tension line (RTL) suture closure
Number of subjects: 190
Study 21831931 — intervention group
Group type: COMPARATOR
Intervention: Continuous suturing
Number of subjects: 190
Study 19473833 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin plus pemetrexed (500 mg/m2 pemetrexed IV followed by 75 mg/m2 cisplatin IV on day 1)
Number of subjects: 1669
Study 19473833 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin plus pemetrexed
Number of subjects: 1669
Study 19473833 — intervention group
Group type: COMPARATOR
Intervention: Cisplatin plus gemcitabine (1250 mg/m2 on days 1 and 8 and 75 mg/m2 cisplatin on day 1)
Number of subjects: 1669
Study 17905807 — intervention group
Group type: EXPERIMENTAL
Intervention: Sibling number in the household
Number of subjects: 3928
Study 17905807 — intervention group
Group type: EXPERIMENTAL
Intervention: Birth order
Number of subjects: 3928
Study 15106069 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct transosseous refixation
Number of subjects: 38
Study 15106069 — intervention group
Group type: EXPERIMENTAL
Intervention: Local tendon shifts
Number of subjects: 38
Study 15106069 — intervention group
Group type: EXPERIMENTAL
Intervention: Deltoid flaps
Number of subjects: 38
Study 15106069 — intervention group
Group type: EXPERIMENTAL
Intervention: Reconstruction with intact tendons
Number of subjects: 38
Study 15106069 — intervention group
Group type: EXPERIMENTAL
Intervention: Reconstruction with re-tear
Number of subjects: 38
Study 11800185 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily brief preference assessments
Number of subjects: 5
Study 11800185 — intervention group
Group type: COMPARATOR
Intervention: Lengthy paired-choice preference assessments
Number of subjects: 5
Study 9740601 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium reduction
Number of subjects: 1509
Study 9740601 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1509
Study 9740601 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss
Number of subjects: 1509
Study 7979291 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapsone 200 mg weekly
Number of subjects: 52
Study 7979291 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapsone 200 mg plus pyrimethamine 25 mg weekly
Number of subjects: 52
Study 7979291 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapsone 200 mg plus pyrimethamine 75 mg weekly
Number of subjects: 52
Study 2657024 — intervention group
Group type: EXPERIMENTAL
Intervention: Enamelbond, Heliobond, and Scotchbond
Number of subjects: 350
Study 2657024 — intervention group
Group type: EXPERIMENTAL
Intervention: Dentin‐Adhesit and Scotchbond
Number of subjects: 350
Study 2657024 — intervention group
Group type: EXPERIMENTAL
Intervention: P10/Dentin‐Adhesit and Silar/Scotchbond
Number of subjects: 350
Study 31292959 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel meat product with apple fiber (0.15%), rice starch (0.30%), and citric acid (0.16 M)
Number of subjects: 0
Study 31292959 — intervention group
Group type: COMPARATOR
Intervention: Control (traditional beef product)
Number of subjects: 0
Study 29194698 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban 20 mg oral dose with verapamil
Number of subjects: 0
Study 28829876 — intervention group
Group type: EXPERIMENTAL
Intervention: NT-proBNP-guided strategy (n=446)
Number of subjects: 894
Study 28829876 — intervention group
Group type: COMPARATOR
Intervention: Usual care (n=448)
Number of subjects: 894
Study 26161426 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentax-AWS (AWS)
Number of subjects: 19
Study 26161426 — intervention group
Group type: EXPERIMENTAL
Intervention: Glidescope (GVL)
Number of subjects: 19
Study 26161426 — intervention group
Group type: COMPARATOR
Intervention: Macintosh Laryngoscope (MCL)
Number of subjects: 19
Study 22836861 — intervention group
Group type: EXPERIMENTAL
Intervention: Early oral refeeding (EORF)
Number of subjects: 149
Study 22836861 — intervention group
Group type: COMPARATOR
Intervention: Routine oral refeeding (RORF)
Number of subjects: 149
Study 20947072 — intervention group
Group type: EXPERIMENTAL
Intervention: Transvaginal three-dimensional ultrasonography and power Doppler angiography
Number of subjects: 134
Study 18551287 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of T1-weighted images (T1WI), T2-weighted images (T2WI), and fluid-attenuated inversion recovery (FLAIR) images
Number of subjects: 45
Study 18551287 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of T1WI and FLAIR images
Number of subjects: 45
Study 18551287 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of T2WI and FLAIR images
Number of subjects: 45
Study 18551287 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of T1WI and T2WI images
Number of subjects: 45
Study 18551287 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of T1WI, T2WI, and FLAIR images
Number of subjects: 45
Study 14745057 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine 5 mg/kg IV during 30 minutes
Number of subjects: 22
Study 14745057 — intervention group
Group type: EXPERIMENTAL
Intervention: Mexiletine titrated from 400 to 1,000 mg per day (mean 737 mg/day)
Number of subjects: 22
Study 14745057 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 11252361 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermoradiotherapy (TRT)
Number of subjects: 40
Study 11252361 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy (RT)
Number of subjects: 40
Study 9852694 — intervention group
Group type: COMPARATOR
Intervention: propofol 2.5 mg.kg‐1
Number of subjects: 94
Study 9852694 — intervention group
Group type: EXPERIMENTAL
Intervention: pentazocine 0.3 mg.kg‐1 followed by thiamylal 5 mg.kg‐1
Number of subjects: 94
Study 9852694 — intervention group
Group type: EXPERIMENTAL
Intervention: pentazocine 0.6 mg.kg‐1 followed by thiamylal 5 mg.kg‐1
Number of subjects: 94
Study 9852694 — intervention group
Group type: EXPERIMENTAL
Intervention: thiamylal 5 mg.kg‐1
Number of subjects: 94
Study 9852694 — intervention group
Group type: EXPERIMENTAL
Intervention: pentazocine groups
Number of subjects: 94
Study 9852694 — intervention group
Group type: COMPARATOR
Intervention: propofol
Number of subjects: 94
Study 9852694 — intervention group
Group type: EXPERIMENTAL
Intervention: all groups
Number of subjects: 94
Study 8208390 — intervention group
Group type: EXPERIMENTAL
Intervention: Phentolamine (35 mg)
Number of subjects: 100
Study 8208390 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenylephrine (500 micrograms)
Number of subjects: 100
Study 8208390 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 100
Study 8208390 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 100
Study 2927132 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol (0.7 g/kg, p.o.)
Number of subjects: 1
Study 2927132 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1
Study 30343415 — intervention group
Group type: EXPERIMENTAL
Intervention: Right groin incision with adipocutaneous flap
Number of subjects: 100
Study 30343415 — intervention group
Group type: COMPARATOR
Intervention: McBurney's incision
Number of subjects: 100
Study 27501650 — intervention group
Group type: EXPERIMENTAL
Intervention: 30-mL normal saline bolus
Number of subjects: 46
Study 27501650 — intervention group
Group type: COMPARATOR
Intervention: Sham (control)
Number of subjects: 46
Study 24848178 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal anesthesia
Number of subjects: 66
Study 24848178 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia
Number of subjects: 66
Study 22554751 — intervention group
Group type: EXPERIMENTAL
Intervention: Etching with 30% phosphoric acid for 15 seconds with daily brushing
Number of subjects: 90
Study 22554751 — intervention group
Group type: EXPERIMENTAL
Intervention: Etching with 30% phosphoric acid for 15 seconds with no brushing
Number of subjects: 90
Study 22554751 — intervention group
Group type: EXPERIMENTAL
Intervention: Etching with 30% phosphoric acid for 30 seconds with daily brushing
Number of subjects: 90
Study 22554751 — intervention group
Group type: EXPERIMENTAL
Intervention: Etching with 30% phosphoric acid for 30 seconds with no brushing
Number of subjects: 90
Study 22554751 — intervention group
Group type: COMPARATOR
Intervention: Non-etched control with daily brushing
Number of subjects: 90
Study 22554751 — intervention group
Group type: COMPARATOR
Intervention: Non-etched control with no brushing
Number of subjects: 90
Study 21322301 — intervention group
Group type: EXPERIMENTAL
Intervention: ARI Quality Dashboard
Number of subjects: 258
Study 21322301 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 258
Study 18852529 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 g/d glycine
Number of subjects: 74
Study 18852529 — intervention group
Group type: COMPARATOR
Intervention: 5 g/d placebo
Number of subjects: 74
Study 15838160 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsatile perfusion
Number of subjects: 40
Study 15838160 — intervention group
Group type: COMPARATOR
Intervention: Continuous flow
Number of subjects: 40
Study 11262783 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human erythropoietin (300 U/kg twice a week)
Number of subjects: 40
Study 11262783 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 11262783 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human erythropoietin (300 U/kg twice a week) and preoperative autologous blood donation
Number of subjects: 40
Study 11262783 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous blood administration without concurrent erythropoietin
Number of subjects: 40
Study 9916899 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipenem
Number of subjects: 0
Study 9916899 — intervention group
Group type: COMPARATOR
Intervention: Targeted therapy
Number of subjects: 0
Study 8063348 — intervention group
Group type: EXPERIMENTAL
Intervention: Isotonic training (5BX programme)
Number of subjects: 0
Study 8063348 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric training (a programme of isometric exercises)
Number of subjects: 0
Study 8063348 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific workout)
Number of subjects: 0
Study 3377382 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilocarpine 4% gel
Number of subjects: 0
Study 3377382 — intervention group
Group type: COMPARATOR
Intervention: Pilocarpine 4% solution
Number of subjects: 0
Study 31136659 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 cup of blueberries per day
Number of subjects: 115
Study 31136659 — intervention group
Group type: COMPARATOR
Intervention: 1/2 cup of blueberries per day
Number of subjects: 115
Study 31136659 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 115
Study 28432266 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-Arterial Treatment (IAT)
Number of subjects: 0
Study 25369890 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcifediol (20 μg per day)
Number of subjects: 20
Study 25369890 — intervention group
Group type: COMPARATOR
Intervention: Vitamin D3 (20 μg or 800 IU per day)
Number of subjects: 20
Study 25369890 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcifediol
Number of subjects: 20
Study 25369890 — intervention group
Group type: COMPARATOR
Intervention: Vitamin D3
Number of subjects: 20
Study 23289005 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous adhesiolysis with caudal epidural injections, including 5 mL of 2% preservative-free lidocaine, 6 mL of 10% hypertonic sodium chloride solution, and 6 mg of non-particulate betamethasone.
Number of subjects: 70
Study 23289005 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous adhesiolysis
Number of subjects: 70
Study 22321500 — intervention group
Group type: EXPERIMENTAL
Intervention: MICS group (coaxial 1.8 mm microincision cataract surgery)
Number of subjects: 89
Study 22321500 — intervention group
Group type: COMPARATOR
Intervention: SICS group (coaxial 3 mm small-incision cataract surgery)
Number of subjects: 89
Study 19212794 — intervention group
Group type: EXPERIMENTAL
Intervention: Reflux events in patients with primary respiratory symptoms (RS)
Number of subjects: 30
Study 19212794 — intervention group
Group type: COMPARATOR
Intervention: Reflux events in patients with primary esophageal symptoms (ES)
Number of subjects: 30
Study 19212794 — intervention group
Group type: EXPERIMENTAL
Intervention: Proximal reflux events in patients with primary respiratory symptoms (RS)
Number of subjects: 30
Study 19212794 — intervention group
Group type: COMPARATOR
Intervention: Proximal reflux events in patients with primary esophageal symptoms (ES)
Number of subjects: 30
Study 16455222 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle physical activity counseling program with feedback of a pedometer during pulmonary rehabilitation
Number of subjects: 21
Study 16455222 — intervention group
Group type: COMPARATOR
Intervention: Control group (only followed rehabilitation)
Number of subjects: 21
Study 16455222 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group
Number of subjects: 21
Study 15315996 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D-CRT plus 6 months of AST
Number of subjects: 206
Study 15315996 — intervention group
Group type: COMPARATOR
Intervention: 3D-CRT alone
Number of subjects: 206